Dallas Formulations Private Limited

Pharmaceutical company manufacturing a wide range of products for various Indian companies.

2000 | Ujjain, Madhya Pradesh (India) | Active
Last Updated:

Dallas Formulations Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 3.91 M
  • Company Age 24 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.95 Cr
  • Satisfied Charges ₹ 3.95 Cr
  • Revenue Growth -6.75%
  • Profit Growth 501.87%
  • Ebitda 18.82%
  • Net Worth 4.20%
  • Total Assets 4.27%

About Dallas Formulations

Dallas Formulations Private Limited (DFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 November 2000 and has a history of 24 years and five months. Its registered office is in Ujjain, Madhya Pradesh, India.

The Corporate was formerly known as Chirayu Ayurveda Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.91 M.

The company currently has active open charges totaling ₹3.95 Cr. The company has closed loans amounting to ₹3.95 Cr, as per Ministry of Corporate Affairs (MCA) records.

Rajesh Gupta and Mukesh Kumar serve as directors at the Company.

Company Details

  • Location

    Ujjain, Madhya Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233MP2000PTC014476

  • Company No.

    014476

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    24 Nov 2000

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Gwalior

Industry

Pharma
Company report

Dallas Formulations Private Limited

Explore comprehensive data for Dallas Formulations Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Dallas Formulations?

Board Members (2)

NameDesignationAppointment DateStatus
Rajesh Gupta Country flag representing In Director 16-Jan-2006Current
Mukesh Kumar Country flag representing In Whole-Time Director 21-Jul-2022Current

Financial Performance of Dallas Formulations.

Dallas Formulations Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.75% decrease. The company also saw a substantial improvement in profitability, with a 501.87% increase in profit. The company's net worth moved up by a moderate rise of 4.2%.

Dallas Formulations revenue growth over time
Dallas Formulations profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-6.75%
Revenue from Operations
-8.27%
Total Assets
4.27%
Profit or Loss
501.87%
Net Worth
4.20%
EBITDA
18.82%

What is the Ownership and Shareholding Structure of Dallas Formulations?

In 2024, Dallas Formulations had a public holding of 40.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹39.51 M

Satisfied Charges

₹39.50 M

Charges Breakdown by Lending Institutions

  • State Bank Of India : 2.66 Cr
  • Dir. Of Industries With Parri Passu Sbi Baddi : 1.29 Cr

Latest Charge Details

DateLenderAmountStatus
17 Aug 2011Dir. Of Industries With Parri Passu Sbi Baddi₹1.29 CrOpen
11 Nov 2006State Bank Of India₹2.66 CrOpen
28 Nov 2013Ing Vysya Bank Limited₹1.75 CrSatisfied
29 Apr 2006State Bank Of India₹2.20 CrSatisfied

How Many Employees Work at Dallas Formulations?

Dallas Formulations has a workforce of 22 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Dallas Formulations Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dallas Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dallas Formulations's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dallas Formulations

Recent activity within the organization

  • Annual General Meeting

    Dallas Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Dallas Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.

  • Charges

    A charge with State Bank Of India of Rs. 26.60 M registered on 11 Nov 2006 with Charge ID 10030257 was modified on 15 May 2023.

  • Director Appointment

    Mukesh Kumar was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 21 Jul 2022 & has been associated with this company since 2 years 9 months .

  • Charges

    A charge registered on 28 Nov 2013 via Charge ID 10466437 with Ing Vysya Bank Limited was fully satisfied on 29 Oct 2014.

  • Charges

    A charge with Ing Vysya Bank Limited amounted to Rs. 17.50 M with Charge ID 10466437 was registered on 28 Nov 2013.

Frequently asked questions

  • What is the Incorporation or founding date of Dallas Formulations Private Limited?

    Dallas Formulations Private Limited was incorporated on 24 Nov 2000.

  • What is authorized share capital and paid-up capital of Dallas Formulations Private Limited?

    The authorized share capital of Dallas Formulations Private Limited is ₹ 5.00 M and paid-up capital is ₹ 3.91 M.

  • Who are the current board members & directors of Dallas Formulations Private Limited?

    Currently 2 directors are associated with Dallas Formulations Private Limited.

    • Rajesh Gupta
    • Mukesh Kumar

  • What is the registered address of Dallas Formulations Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Dallas Formulations Private Limited is 220 Block-C 2Nd Floor Madhav Club Road, Dawa Bazar India, Ujjain, Madhya Pradesh, 456010.

  • What is the corporate identification number (CIN) and company number of Dallas Formulations Private Limited?

    The corporate identification number (CIN) of Dallas Formulations Private Limited is U24233MP2000PTC014476 and the company number is 014476 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Dallas Formulations Private Limited?

    The Official website of Dallas Formulations Private Limited is https://www.dallaspharma.com

  • What has been the recent revenue trend for Dallas Formulations Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Dallas Formulations Private Limited has fallen by -6.75%.

  • How many employees does Dallas Formulations Private Limited currently have?

    As Per 2024 financial reports, 22 employees are currently employed by Dallas Formulations Private Limited.

  • What change has been observed in the net worth of Dallas Formulations Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Dallas Formulations Private Limited has experienced an upsurge of 4.20%.

  • What are the total open charges for Dallas Formulations Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Dallas Formulations Private Limited amount to ₹ 3.95 Cr.

  • When was the last Balance Sheet of Dallas Formulations Private Limited filed with the ROC?

    The most recent Balance Sheet for Dallas Formulations Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development